Patient Satisfaction in Stroke Patients (PatZuFrie)

This study has been completed.
Sponsor:
Collaborators:
Center for Stroke Research Berlin
German Federal Ministry of Education and Research
Information provided by:
Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT00994409
First received: October 13, 2009
Last updated: November 30, 2010
Last verified: November 2010
  Purpose

The objective of this trial is to guarantee a follow-up of all stroke and transient ischemic attack (TIA) patients. With this follow-up assessment long term effects of therapy and prevention measures can be detected and monitored. It is part of quality assurance.


Condition
Stroke

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Berliner Schlaganfallregister - Nachbefragung Von Patienten Mit Schlaganfall

Further study details as provided by Charite University, Berlin, Germany:

Primary Outcome Measures:
  • Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness. [ Time Frame: September 2010 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Compliance/adherence with discharge medication Activities of daily living [ Time Frame: September 2010 ] [ Designated as safety issue: No ]
  • Re-events [ Time Frame: September 2010 ] [ Designated as safety issue: No ]
  • Degree of Disability [ Time Frame: September 2010 ] [ Designated as safety issue: No ]
  • Mortality [ Time Frame: September 2010 ] [ Designated as safety issue: No ]

Estimated Enrollment: 1200
Study Start Date: July 2008
Study Completion Date: November 2010
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Detailed Description:

Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness Key secondary endpoint(s): Compliance/adherence with discharge medication. Re-events. Degree of Disability. Activities of daily living. Mortality.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Stroke and TIA patients treated at the Charite with acute stroke or TIA onset less than 7 days

Criteria

Inclusion Criteria:

  • all patients eligible

Exclusion Criteria:

  • none
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00994409

Locations
Germany
Dept. Neurology, Charité Campus Benjamin Franklin
Berlin, Germany
Sponsors and Collaborators
Charite University, Berlin, Germany
Center for Stroke Research Berlin
German Federal Ministry of Education and Research
Investigators
Principal Investigator: Peter U Heuschmann, Professor Center for Stroke Research Berlin
  More Information

No publications provided

Responsible Party: Christian H Nolte MD, Dept. Neurology, Charite Campus Benjamin Franklin
ClinicalTrials.gov Identifier: NCT00994409     History of Changes
Other Study ID Numbers: CSB-PatZuFrie, EA4/019/08
Study First Received: October 13, 2009
Last Updated: November 30, 2010
Health Authority: Germany: Ethics Commission

Keywords provided by Charite University, Berlin, Germany:
Stroke

Additional relevant MeSH terms:
Stroke
Cerebral Infarction
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Brain Infarction
Brain Ischemia

ClinicalTrials.gov processed this record on September 18, 2014